Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9318
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLi, Yang-
dc.contributor.authorHuang, Shih-Tse-
dc.contributor.authorChen, Wan-Chin-
dc.contributor.authorHuang, Wan-Ting-
dc.contributor.authorChen, Fu-Jun-
dc.contributor.authorLin, Min-Tsung-
dc.date.accessioned2024-12-19T04:08:04Z-
dc.date.available2024-12-19T04:08:04Z-
dc.date.issued2023-04-
dc.identifier.citationOriginal Articleen_US
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/9318-
dc.description.abstractAbstract Background: COVID-19 and influenza have similar clinical presentations that can range from mild to severe disease. The World Health Organization recommends that countries use existing influenza surveillance to monitor COVID-19 transmission in communities. We aim to describe the surveillance and investigation of COVID-19 at the early stage of the pandemic in Taiwan. Methods: In February 2020, the Taiwan Centers for Disease Control enhanced COVID-19 surveillance through its existing influenza surveillance. We retrospectively tested patients for SARSCoV-2 who had symptoms of severe complicated influenza but were negative in influenza testing. We conducted an epidemiological investigation and contact tracing for the index patient and secondary cases to prevent virus transmission. Results: We identified the first COVID-19 patient on February 15 through enhanced COVID-19 surveillance. He had no history of traveling abroad and an unclear history of contact with COVID-19 cases. He presented with influenza-like illness on January 27 and was hospitalized from February 3 to 15. We identified 39 close contacts of the index patient, including 11 family members and 28 healthcare workers. In total, four close family contacts of the index patient tested positive for SARS-CoV-2. An additional 84 close contacts of the four secondary cases were identified and traced; none was diagnosed with COVID-19. Conclusions: We recommend enhancing COVID-19 surveillance by testing patients with influenza-like illness. To prevent the spread of COVID-19, we recommend using appropriate personal protective equipment when in close contact with patients who present with influenza-like illness or when caring for patients with pneumonia of unknown etiology.en_US
dc.language.isoen_USen_US
dc.publisherElsevier Taiwan LLCen_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2en_US
dc.subjectInfluenza surveillanceen_US
dc.subjectEpidemiological investigationen_US
dc.subjectContact tracingen_US
dc.titleEpidemiological investigation of the first locally acquired case of COVID-19 identified by influenza surveillancedTaiwan, February 2020en_US
dc.typeArticleen_US
Appears in Collections:VOL 56 NO 3 2023

Files in This Item:
File Description SizeFormat 
499-505.pdf1.23 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.